Transgene S.A. Strasbourg (France), February 6, 2025, 5:45 p.m. CET—Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback